ITP
Iron Triangle Partners Portfolio holdings
AUM
$632M
This Quarter Return
+6.25%
1 Year Return
+26.53%
3 Year Return
+134.07%
5 Year Return
+312.1%
10 Year Return
–
AUM
$632M
AUM Growth
+$632M
(-0.39%)
Cap. Flow
-$39.6M
Cap. Flow
% of AUM
-6.27%
Top 10 Holdings %
Top 10 Hldgs %
60.18%
Holding
37
New
9
Increased
7
Reduced
10
Closed
10
Top Buys
| 1 |
CVS Health
CVS
|
$51.7M |
| 2 |
Charles River Laboratories
CRL
|
$48.6M |
| 3 |
Icon
ICLR
|
$36.4M |
| 4 |
Medtronic
MDT
|
$34.9M |
| 5 |
HCA Healthcare
HCA
|
$30.6M |
Top Sells
| 1 |
DaVita
DVA
|
$48.9M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$34.1M |
| 3 |
Boston Scientific
BSX
|
$33.5M |
| 4 |
Cardinal Health
CAH
|
$32.7M |
| 5 |
Globus Medical
GMED
|
$31.6M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
CVS Health
CVS
$92.8B
| $51.7M | 7.94% | +750,000 | New | +$51.7M |
|
|
2
Charles River Laboratories
CRL
$8.04B
| $48.6M | 7.46% | +320,000 | New | +$48.6M |
|
3
AbbVie
ABBV
$372B
| $46.4M | 7.13% | 249,997 +57,178 | +30% | +$10.6M |
|
4
Merit Medical Systems
MMSI
$5.36B
| $36.7M | 5.64% | 392,783 +163,045 | +71% | +$15.2M |
|
|
5
Icon
ICLR
$13.8B
| $36.4M | 5.58% | +250,000 | New | +$36.4M |
|
|
6
Medtronic
MDT
$119B
| $34.9M | 5.35% | +400,000 | New | +$34.9M |
|
7
Tenet Healthcare
THC
$16.3B
| $33.4M | 5.14% | 190,000 -19,454 | -9% | -$3.42M |
|
8
Intuitive Surgical
ISRG
$170B
| $32.6M | 5.01% | 60,000 +30,000 | +100% | +$16.3M |
|
|
9
HCA Healthcare
HCA
$94.5B
| $30.6M | 4.71% | +80,000 | New | +$30.6M |
|
10
Doximity
DOCS
$12.7B
| $28.9M | 4.44% | 471,300 +111,300 | +31% | +$6.83M |
|
11
BrightSpring Health Services
BTSG
$4.2B
| $28.3M | 4.35% | 1,200,000 +477,659 | +66% | +$11.3M |
|
12
Glaukos
GKOS
$5.5B
| $28M | 4.3% | +271,163 | New | +$28M |
|
13
Insulet
PODD
$23.9B
| $21.4M | 3.28% | 68,041 -37,988 | -36% | -$11.9M |
|
14
AdaptHealth
AHCO
$1.28B
| $18.1M | 2.78% | 1,920,019 +305,974 | +19% | +$2.89M |
|
|
15
Cardinal Health
CAH
$35.5B
| $17.7M | 2.72% | 105,257 -194,743 | -65% | -$32.7M |
|
16
Adaptive Biotechnologies
ADPT
$2.01B
| $17.4M | 2.68% | 1,495,883 -638,178 | -30% | -$7.43M |
|
17
Exact Sciences
EXAS
$8.98B
| $15.9M | 2.45% | +300,000 | New | +$15.9M |
|
18
Twist Bioscience
TWST
$1.63B
| $15.6M | 2.4% | 424,355 +442 | +0.1% | +$16.3K |
|
19
Guardant Health
GH
$8.41B
| $15.6M | 2.4% | 300,000 -300,867 | -50% | -$15.7M |
|
|
ONC
20
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $14.5M | 2.23% | 60,000 -37,840 | -39% | -$9.16M |
|
21
Envista
NVST
$3.52B
| $12.1M | 1.86% | 620,000 -612,798 | -50% | -$12M |
|
22
Brookdale Senior Living
BKD
$1.83B
| $11.8M | 1.82% | +1,700,000 | New | +$11.8M |
|
23
Enhabit
EHAB
$399M
| $9.91M | 1.52% | 1,027,972 -112,028 | -10% | -$1.08M |
|
24
Alnylam Pharmaceuticals
ALNY
$58.5B
| $9.57M | 1.47% | 29,339 -36,070 | -55% | -$11.8M |
|
25
argenx
ARGX
$43.6B
| $8.58M | 1.32% | 15,567 -12,307 | -44% | -$6.78M |
|